Shopping Cart 0
Cart Subtotal
USD 0

Regenerative Medicine Market - Global Forecast upto 2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 3500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 4000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 5000
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Global Regenerative Medicine Market-Drivers, Opportunities, Trends, and Forecasts: 2018-2024
Overview: Regenerative medicine is an interdisciplinary field that applies life science and engineering principles for the regeneration or repair of injured/diseased tissues or organs resulting from various causes including, disease, defects, trauma, and aging. The field includes the generation and use of tissue engineering, therapeutic stem cells and the production of artificial organs. It also allows scientists to grow organs or tissues in the lab and implant them in the body safely when the body fails to heal itself. Notably, it has great potential to solve the problem of organ shortage. According to the estimation of World Health Organization, there is an increasing prevalence of diabetes among adults over the age of 18 years, that has increased to 8.5% in 2014 compared to 4.5% in 1980 across the globe. As per the estimation of Arthritis Foundation, the number of people expected to be diagnosed from arthritis will be more than 78 million, by 2040.
The market for regenerative medicine is driven by increasing prevalence of the neuronal disease, cancer, and genetic disease, emerging application of regenerative medicine, and advancement in technology. The huge number of ongoing clinical trials and strong product pipeline are providing market growth opportunity. The high cost of the treatment, regulatory issues and ethical issues hampering the market growth.
Market Analysis: The Global Regenerative Medicine market is estimated to witness a CAGR of 16.6% during the forecast period 2018-2024. The global market is analyzed based on three segments-Therapy, Application, and regions.
Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). North America is the major shareholder in the global regenerative medicine market, followed by Europe. Asia-Pacific region is expected to have the fastest growth rate with the market growth centered at Japan, China, and India. This is mainly due to increasing funding in healthcare research, rising research activities, growing patient pool, the flexible regulatory environment for clinical trials, and rising healthcare expenditure.
Therapy Analysis: Immunotherapy occupied the major market share of the global regenerative medicine market in 2017, and is expected to remain the same during the forecasted period. Increasing product approvals, emerging technological advancements in cell and gene therapy, flexible regulatory for stem cell-based research, and growing awareness regarding the benefits of stem cell therapies.
Application Analysis: The market by application is segmented into cancer, central nervous system, orthopedic and musculoskeletal, diabetes, dermatology, cardiovascular and others. Among various application, dermatology occupied the largest share in 2017 and the cancer segment is expected to grow at the fastest rate during the forecasted period. The growing aging population, changing lifestyle, increasing disease prevalence makes cancer, the fastest growing application segment during the forecasted period.
Key Players: Allergan plc, Integra Lifesciences, Mimedx Group, Inc., Medtronic plc, Organogenesis Inc., Zimmer Biomet, Acelity L.P. Inc., Nuvasive, Inc., Stryker Corporation, Japan Tissue Engineering Co., Ltd. (Fujifilm Holdings Corporation subsidiary), Osiris Therapeutics, Inc., Vericel Corporation and other predominate and niche players.
Competitive Analysis: Currently dermatology segment dominates the global regenerative medicine segment. A lot of researches are going on cancer, CNS, cardiovascular, orthopedic & musculoskeletal applications. The increasing importance of regenerative medicine has resulted in the launch of new products and also increased acquisition, approvals, funding to develop the new product. For instance, in August 2017, Tissue Regenix Group plc completed the acquisition of CellRight Technologies, an US-based specialist in regenerative osteoinductive bone scaffolds. In April 2018, Roche acquired a program named Inception 5, focused on regenerative therapies for multiple sclerosis. In May 2018, Novartis received second FDA approval for Kymriah, CAR-T cell therapy for B-cell acute lymphoblastic leukemia (ALL).
Benefits: The report provides complete details about the usage and adoption rate of regenerative medicine in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player's initiatives. Moreover, the report provides details about the major challenges that are going to impact on market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.
Key Stakeholders:
 
READ MORE

Table Of Content

Scope

Table of Contents

1 Industry Outlook

1.1 Industry Overview

1.2 Total addressable market

2 Report Outline

2.1 Report Scope

2.2 Report Summary

2.3 Research Methodology

2.4 Report Assumptions

3 Market Snapshot

3.1 Market Definition-Infoholic Research

3.2 Advantages of regenerative medicine

3.3 Disadvantage of regenerative medicine

3.4 Segmented Addressable Market (SAM)

3.5 Trends of the regenerative medicine market

3.6 Related Markets

3.6.1 Wound Biologics

Trends of Wound Biologics market

3.6.2 Stem cell banking

Trends of stem banking market

4 Market Outlook

4.1 Market segmentation

4.2 PEST Analysis

4.3 Porter 5(Five) Forces

5 Market Characteristics

5.1 DRO-Global Regenerative Medicine Market Dynamics

5.1.1 Drivers

5.1.1.1 Increasing incidence of disease

5.1.1.2 Wide application range of regenerative medicine

5.1.1.3 Technological advancement

5.1.2 Opportunities

5.1.2.1 Huge number of ongoing clinical trails and strong portfolio of product pipelin

5.1.2.2 Increased collaboration and partnership

5.1.3 Restraints

5.1.3.1 High treatment cost

5.1.3.2 Ethical issues

5.2 DRO-Impact Analysis

5.3 Key Stakeholders

6 Therapy: Market Size & Analysis

6.1 Overview

6.2 Cell therapy

6.3 Gene Therapy

6.4 Tissue Engineering

6.5 Biologics and Small molecules

7 Applications: Market Size & Analysis

7.1 Overview

7.2 Cancer

7.3 Central Nervous System (CNS)

7.4 Diabetes

7.5 Cardiovascular disease

7.6 Dermatology

7.7 Orthopedic and Musculoskeletal

7.8 Others

8 Regions: Market Size and Analysis

8.1 Overview

8.2 North America

8.2.1 US 40

8.2.2 Canada

8.3 Europe

8.3.1 UK 42

8.3.2 Germany

8.3.3 France

8.3.4 Spain

8.4 Asia Pacific

8.4.1 India

8.4.2 China

8.4.3 Japan

8.5 Rest of the World

9 Competitive Landscape

9.1 Overview

10 Vendor Profiles

10.1 Medtronic Plc

10.1.1 Overview

10.1.2 Business Units

10.1.3 Geographic Presence

10.1.4 Business Focus

10.1.5 SWOT Analysis

10.1.6 Business Strategies

10.2 Organogenesis Inc

10.2.1 Overview

10.2.2 Business Focus

10.2.3 SWOT Analysis

10.2.4 Business Strategies

10.3 Integra Life Sciences Corp.

10.3.1 Overview

10.3.2 Business Units

10.3.3 Geographic Presence

10.3.4 Business Focus

10.3.5 SWOT Analysis

10.3.6 Business Strategies

10.4 MiMedx Group

10.4.1 Overview

10.4.2 Business Focus

10.4.3 SWOT Analysis

10.4.4 Business Strategies

10.5 Zimmer Biomet Holdings, Inc.

10.5.1 Overview

10.5.2 Business Units

10.5.3 Geographic Presence

10.5.4 Business Focus

10.5.5 SWOT Analysis

10.5.6 Business Strategies

11 Companies to Watch for

11.1 Novartis AG

11.1.1 Overview

11.2 Allergan plc

11.2.1 Overview

11.3 Vericel Corporation

11.3.1 Overview

11.4 NuVasive, Inc.

11.4.1 Overview

11.5 Vertex Pharmaceutical Incorporated

11.5.1 Overview

11.6 Acelity LP

11.6.1 Overview

11.7 Osiris Therapeutics, Inc.

11.7.1 Overview

11.7.2 Highlights

Annexure

Acronyms


List Of Figure

Charts

CHART 1 RESEARCH METHODOLOGY OF GLOBAL REGENERATIVE MEDICINE MARKET 11

CHART 2 GLOBAL REGENERATIVE MEDICINE MARKET REVENUE, 2017-2024 (USD MILLION) 15

CHART 3 SEGMENTATION OF GLOBAL REGENERATIVE MEDICINE MARKET 19

CHART 4 PEST ANALYSIS OF GLOBAL REGENERATIVE MEDICINE MARKET 19

CHART 5 PORTER 5 FORCES ON GLOBAL REGENERATIVE MEDICINE MARKET 20

CHART 6 DRO-IMPACT ANALYSIS OF GLOBAL REGENERATIVE MEDICINE MARKET 27

CHART 7 KEY STAKEHOLDERS 27

CHART 8 GLOBAL REGENERATIVE MARKET BY THERAPY SEGMENTATION, 2017 (%) 29

CHART 9 GLOBAL CELL THERAPY MARKET FORECAST, 2017-2024 (USD MILLION) 30

CHART 10 GLOBAL GENE THERAPY MARKET FORECAST, 2017-2024 (USD MILLION) 32

CHART 11 GLOBAL TISSUE ENGINEERING MARKET FORECAST, 2017-2024 (USD MILLION) 33

CHART 12 GLOBAL BIOLOGICS AND SMALL MOLECULES MARKET FORECAST, 2017-2024 (USD MILLION) 34

CHART 13 GLOBAL REGENERATIVE MEDICINE MARKET BY APPLICATION SEGMENTATION, 2017 (%) 35

CHART 14 GLOBAL REGENERATIVE MEDICINE MARKET BY GEOGRAPHICAL SEGMENTATION, 2017 (%) 39

CHART 15 REGENERATIVE MEDICINE MARKET REVENUE IN NORTH AMERICA, 2017-2024 (USD MILLION) 40

CHART 16 REGENERATIVE MEDICINE MARKET REVENUE IN EUROPE, 2017-2024 (USD MILLION) 42

CHART 17 REGENERATIVE MEDICINE MARKET REVENUE IN ASIA PACIFIC, 2017-2024 (USD MILLION) 44

CHART 18 REGENERATIVE MEDICINE MARKET REVENUE IN REST OF THE WORLD, 2017-2024 (USD MILLION) 46

CHART 19 MEDTRONIC PLC: OVERVIEW SNAPSHOT 58

CHART 20 MEDTRONIC PLC: BUSINESS UNITS 60

CHART 21 MEDTRONIC PLC: GEOGRAPHIC PRESENCE 61

CHART 22 MEDTRONIC PLC: SWOT ANALYSIS 62

CHART 23 ORGANOGENESIS INC: SWOT ANALYSIS 65

CHART 24 INTEGRA LIFE SCIENCES CORP.: OVERVIEW SNAPSHOT 67

CHART 25 INTEGRA LIFE SCIENCES CORP.: BUSINESS UNITS 69

CHART 26 INTEGRA LIFE SCIENCES CORP.: GEOGRAPHIC PRESENCE 70

CHART 27 INTEGRA LIFE SCIENCES CORP.: SWOT ANALYSIS 71

CHART 28 MIMEDX GROUP: OVERVIEW SNAPSHOT 73

CHART 29 MIMEDX: SWOT ANALYSIS 75

CHART 30 ZIMMER BIOMET HOLDINGS, INC.: OVERVIEW SNAPSHOT 78

CHART 31 ZIMMER BIOMET HOLDINGS, INC.: BUSINESS UNITS 80

CHART 32 ZIMMER BIOMET HOLDINGS, INC.: GEOGRAPHIC PRESENCE 81

CHART 33 ZIMMER BIOMET HOLDINGS: SWOT ANALYSIS 82

 

 


List Of Table

Tables

TABLE 1 GLOBAL REGENERATIVE MEDICINE MARKET REVENUE BY REGIONS, 2017-2024 (USD MILLION) 39

TABLE 2 OTHER PROMINENT VENDORS OF REGENERATIVE MEDICINE MARKET 49

TABLE 3 MEDTRONIC PLC: OFFERINGS 50

TABLE 4 MEDTRONIC PLC: RECENT DEVELOPMENTS 51

TABLE 5 ORGANOGENESIS INC: OFFERINGS 63

TABLE 6 ORGANOGENESIS INC: RECENT DEVELOPMENTS 64

TABLE 7 INTEGRA LIFE SCIENCES CORP.: OFFERINGS 66

TABLE 8 INTEGRA LIFE SCIENCES CORP.: RECENT DEVELOPMENTS 66

TABLE 9 MIMEDX: OFFERINGS 72

TABLE 10 MIMEDX GROUP: RECENT DEVELOPMENTS 73

TABLE 11 ZIMMER BIOMET: OFFERINGS 76

TABLE 12 ZIMMER BIOMET HOLDINGS, INC.: RECENT DEVELOPMENTS 78

TABLE 13 NOVARTIS AG.: SNAPSHOT 84

TABLE 14 NOVARTIS AG: RECENT DEVELOPMENTS 85

TABLE 15 ALLERGAN PLC.: SNAPSHOT 86

TABLE 16 ALLERGAN PLC: RECENT DEVELOPMENTS 87

TABLE 17 VERICEL CORPORATION: SNAPSHOT 89

TABLE 18 VERICEL CORPORATION: RECENT DEVELOPMENTS 90

TABLE 19 NUVASIVE, INC.: SNAPSHOT 91

TABLE 20 NUVASIVE, INC.: RECENT DEVELOPMENTS 92

TABLE 21 VERTEX PHARMACEUTICAL INCORPORATED: SNAPSHOT 93

TABLE 22 VERTEX PHARMACEUTICAL INCORPORATED: RECENT DEVELOPMENTS 94

TABLE 23 ACELITY LP: SNAPSHOT 95

TABLE 24 ACELITY LP: RECENT DEVELOPMENTS 96

TABLE 25 OSIRIS THERAPEUTICS, INC: OVERVIEW 96

 

 

Licence Rights

"Single User $3,500- PDF via email with only 1 user license terms or online access with login details to customer
- Multi Users $4,000- PDF via email with up to 10 user license terms
- Enterprise License $5,000- PDF via email, can be utilized across the organization and can upload in their intranet.
We do have the online access for our reports where client can utilize our knowledge store and they will have their login details to access the report online instead of PDF file."

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Allergan plc, Integra lifesciences, Mimedx Group, Inc., Medtronic plc, Organogenesis Inc., Zimmer Biomet, Acelity L.P. Inc., Nuvasive, Inc., Stryker Corporation, Japan Tissue Engineering Co., Ltd. (Fujifilm Holdings Corporation subsidiary), Osiris Therapeutics, Inc., Vericel Corporation and other predominate and niche players